Memory Enhancement Drugs Market, By Drug Class (Cholinesterase Inhibitors, Vitamins & Supplements, Smart Drugs and Cognitive Enhancers (Nootropics), and others), by Route of Administration (Topical, Oral, Injectable), by Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Drug Stores, and Online Pharmacy), by Application (Athletic performance, Disease Treatment, Academic performance, and others), By Country, and By Region Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Memory Enhancement Drugs Market size was valued at USD 7,102.12 Million in 2022, expanding at a CAGR of 5.45% from 2023 to 2030.
Memory-improving medications, commonly referred to as cognitive enhancers or nootropics, are pharmacological substances or dietary supplements used to boost cognitive abilities including memory, concentration, and learning. These medications target brain neurotransmitters and circuits to increase neuronal activity and synaptic plasticity, which can be advantageous for those who have memory problems or want to improve their cognitive abilities. However, continuing research and ethical questions continue to surround their long-term usefulness and safety.
Memory Enhancement Drugs Market- Market Dynamics
- Increasing prevalence of the aging population
Over the course of the projection period, the worldwide market for memory-enhancing pharmaceuticals is anticipated to rise due to the aging population's rising prevalence. According to the Alzheimer's Association, nearly one in five Americans will have moderate cognitive impairment in 2022. This condition is linked to the early start of Alzheimer's disease. Additionally, 6.5 million Americans aged 65 and older were reportedly suffering with the illness in 2022. Additionally, one of the causes that propelled the development of such supplements was the aging population's growing desire for memory enhancement.
Memory Enhancement Drugs Market- Key Insights
- As per the analysis shared by our research analyst, the global Memory Enhancement Drugs market is estimated to grow annually at a CAGR of around 5.45% over the forecast period (2023-2030)
- The Memory Enhancement Drugs industry is projected to grow at a significant rate due to the Increasing prevalence of the aging population
- Based on drug class segmentation, vitamins & supplements were predicted to show maximum market share in the year 2022
- Based on the route of administration segmentation, oral was predicted to show maximum market share in the year 2022
- Based on distribution channel segmentation, hospital pharmacy was the leading type in 2022
- Based on application segmentation, disease treatment was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Memory Enhancement Drugs Market- Segmentation Analysis:
The Global Memory Enhancement Drugs Market is segmented on the basis of Drug Class, Route of Administration, Distribution Channel, Application, and Region.
The market is divided into three categories based on drug class: Cholinesterase Inhibitors, Vitamins & Supplements, Smart Drugs and Cognitive Enhancers (Nootropics), and others. The vitamins & supplements sector dominate the market. The demand for this market is anticipated to rise as people become more aware of the advantages of vitamins and supplements. The prevention of age-related cognitive impairment and developmental illnesses including Alzheimer's and dementia depends significantly on vitamins and dietary supplements.
The market is divided into two categories based on application: athletic performance, Disease Treatment, Academic performance, and others. Due to the rising incidence of neurodegenerative disorders including dementia and Alzheimer's, the market for memory-enhancing drugs is segmented by disease treatment, which is expanding. Since these disorders have an impact on memory and cognitive abilities, there is an increasing need for medications that can reduce symptoms and improve memory in individuals with these disorders.
Memory Enhancement Drugs Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period, owing to an increase in the prevalence of neurological disorders and the presence of a large patient pool are the key factors anticipating the growth of the cognitive and memory enhancer drug market.
Memory Enhancement Drugs Market- Competitive Landscape:
Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Products makers compete on a variety of aspects, including product costs, performance, product making, technology, reputation, and availability. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions.
Recent Developments:
- In April 2022, in a mid-stage clinical study for Alzheimer's disease (AD), a first-in-class oral drug targeting NMDA receptors proved successful, setting the foundation for a comprehensive effectiveness and safety investigation. Twenty-six Alzheimer's patients with moderate cognitive impairment responded better on average on five common memory tests after taking SAGE-718, a PAM of NMDA receptor activation.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MEMORY ENHANCEMENT DRUGS MARKET KEY PLAYERS
- Pfizer Inc.
- UCB S.A
- Takeda Pharmaceutical Company
- Shire plc
- Sanochemia Pharmazeutika AG
- Allergan plc
- Novartis AG
- Alkem Laboratories Ltd.
- Paradigm Healthcare
- Intas Pharmaceutical Ltd
- Taurus Laboratories Pvt. Ltd.
GLOBAL MEMORY ENHANCEMENT DRUGS MARKET, BY DRUG CLASS
- Cholinesterase Inhibitors
- Vitamins & Supplements
- Smart Drugs and Cognitive Enhancers (Nootropics)
- Others
GLOBAL MEMORY ENHANCEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION
- Topical
- Oral
- Injectable
GLOBAL MEMORY ENHANCEMENT DRUGS MARKET, BY DISTRIBUTION CHANNEL
- Retail Pharmacy
- Hospital Pharmacy
- Drug Stores
- Online Pharmacy
GLOBAL MEMORY ENHANCEMENT DRUGS MARKET, BY APPLICATION
- Athletic performance
- Disease Treatment
- Academic performance
- Others
GLOBAL MEMORY ENHANCEMENT DRUGS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Memory Enhancement Drugs Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Memory Enhancement Drugs Market Snippet by Drug Class
2.1.2. Memory Enhancement Drugs Market Snippet by Route of Administration
2.1.3. Memory Enhancement Drugs Market Snippet by Distribution Channel
2.1.4. Memory Enhancement Drugs Market Snippet by Application
2.1.5. Memory Enhancement Drugs Market Snippet by Country
2.1.6. Memory Enhancement Drugs Market Snippet by Region
2.2. Competitive Insights
3. Memory Enhancement Drugs Key Market Trends
3.1. Memory Enhancement Drugs Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Memory Enhancement Drugs Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Memory Enhancement Drugs Market Opportunities
3.4. Memory Enhancement Drugs Market Future Trends
4. Memory Enhancement Drugs Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Memory Enhancement Drugs Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Memory Enhancement Drugs Market Landscape
6.1. Memory Enhancement Drugs Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Memory Enhancement Drugs Market – By Drug Class
7.1. Overview
7.1.1. Segment Share Analysis, By Drug Class, 2022 & 2030 (%)
7.1.2. Cholinesterase Inhibitors
7.1.3. Vitamins & Supplements
7.1.4. Smart Drugs and Cognitive Enhancers (Nootropics)
7.1.5. Others
8. Memory Enhancement Drugs Market – By Route of Administration
8.1. Overview
8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
8.1.2. Topical
8.1.3. Oral
8.1.4. Injectable
9. Memory Enhancement Drugs Market – By Distribution Channel
9.1. Overview
9.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
9.1.2. Retail Pharmacy
9.1.3. Hospital Pharmacy
9.1.4. Drug Stores
9.1.5. Online Pharmacy
10. Memory Enhancement Drugs Market – By Application
10.1. Overview
10.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
10.1.2. Athletic performance
10.1.3. Disease Treatment
10.1.4. Academic performance
10.1.5. Others
11. Memory Enhancement Drugs Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
11.2. North America
11.2.1. Overview
11.2.2. Memory Enhancement Drugs Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.2.4. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.2.7. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Memory Enhancement Drugs Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.3.7. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.9. Italy
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.9.3. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.9.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.9.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.3.9.6. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.10. United Kingdom
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.10.3. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.10.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.10.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.3.10.6. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.11. France
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.11.3. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.11.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.11.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.3.11.6. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.12. Russia
11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.12.2. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.12.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.12.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.3.12.5. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.13. Netherlands
11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.13.2. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.13.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.13.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.3.13.5. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.14. Sweden
11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.14.2. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.15. Poland
11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.15.2. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.15.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.15.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.3.15.5. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.16. Rest of Europe
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.16.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.16.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.16.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.3.16.6. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Memory Enhancement Drugs Key Manufacturers in Asia Pacific
11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.4.7. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.8. India
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.8.3. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.8.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.8.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.4.8.6. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.9. China
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.9.3. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.9.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.9.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.4.9.6. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.13. Thailand
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.13.3. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.13.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.13.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.4.13.6. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.14. Indonesia
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.14.3. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.14.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.14.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.4.14.6. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5. Latin America
11.5.1. Overview
11.5.2. Memory Enhancement Drugs Key Manufacturers in Latin America
11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.5.4. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.5.7. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6. Middle East and Africa
11.6.1. Overview
11.6.2. Memory Enhancement Drugs Key Manufacturers in Middle East and Africa
11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.6.4. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.6.7. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
12. Key Vendor Analysis- Memory Enhancement Drugs Industry
12.1. Competitive Dashboard
12.2. Company Profiles
12.2.1. Pfizer Inc.
12.2.2. UCB S.A
12.2.3. Takeda Pharmaceutical Company
12.2.4. Shire plc
12.2.5. Sanochemia Pharmazeutika AG
12.2.6. Allergan plc
12.2.7. Novartis AG
12.2.8. Alkem Laboratories Ltd.
12.2.9. Paradigm Healthcare
12.2.10. Intas Pharmaceutical Ltd
12.2.11. Taurus Laboratories Pvt. Ltd.
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
